Evidence map›Paper›PMID 40718149›Full record

ArticlePublic health challenges2025

COVID-19 Vaccine Hesitancy, Self-Reported Adverse Events, and Determinants Among Ethiopian Healthcare Professionals During COVID-19 Pandemic.

Alfoalem Araba Abiye, Sisay Endale, Zenebe Negash, Shemsu Umer Hussen, Dawit Teshome Gebregeorgise, Melaku Tileku Tamiru, Dessale Abate Beyene, Hana Shafi Amde, Amanuel Yishak Negash

Abstract read
In one paragraph

Article in Public health challenges, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alfoalem Araba AbiyeDepartment of Pharmacology and Clinical Pharmacy School of Pharmacy College of Health Sciences Addis Ababa University Addis Ababa Ethiopia.ORCID https://orcid.org/0000-0002-8716-8687
Sisay EndaleDepartment of Pharmaceutics and Social Pharmacy School of Pharmacy College of Health Sciences Addis Ababa University Addis Ababa Ethiopia.
Zenebe NegashDepartment of Pharmacology and Clinical Pharmacy School of Pharmacy College of Health Sciences Addis Ababa University Addis Ababa Ethiopia.
Shemsu Umer HussenDepartment of Pharmacology and Clinical Pharmacy School of Pharmacy College of Health Sciences Addis Ababa University Addis Ababa Ethiopia.
Dawit Teshome GebregeorgiseDepartment of Pharmaceutics and Social Pharmacy School of Pharmacy College of Health Sciences Addis Ababa University Addis Ababa Ethiopia.
Melaku Tileku TamiruDepartment of Pharmacology and Clinical Pharmacy School of Pharmacy College of Health Sciences Addis Ababa University Addis Ababa Ethiopia.
Dessale Abate BeyeneDepartment of Pharmacy Asrat Woldeyes Health Science Campus Debre Berhan University Debre Berhan Ethiopia.
Hana Shafi AmdeDepartment of Cardiovascular Nursing School of Nursing and Midwifery College of Health Sciences Addis Ababa University Addis Ababa Ethiopia.
Amanuel Yishak NegashDepartment of Anesthesiology Critical Care and Pain Medicine School of Medicine College of Health Sciences Addis Ababa University Addis Ababa Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This nationwide cross-sectional online survey aimed to assess coronavirus disease 2019 (COVID-19) vaccine hesitancy, self-reported adverse events (SRAEs), and associated determinants among Ethiopian healthcare professionals (HCPs) during the pandemic (June 19-July 31, 2021). This survey collected data from 674 HCPs after the COVID-19 vaccine's first dose became available in Ethiopia. Hesitancy to the first and second vaccine doses was 45.6% and 17.6% among unvaccinated and vaccinated participants, respectively. Fear of side effects (39.9%) and doubts about vaccine effectiveness (29.7%) were the primary reasons for hesitancy toward the first COVID-19 vaccine dose. For the second dose, hesitancy stemmed from perceived lack of difference between vaccinated and unvaccinated individuals (8.4%) and post-first-dose COVID-19 infection (6.4%). The factors associated with hesitancy to receive the COVID-19 vaccine (first dose) were being Muslim (

Indexed as

adverse eventscoronavirus disease 2019 (COVID‐19) vaccinehealthcare professionalsvaccine hesitancy

Identifiers

PMID40718149
PMCPMC12290419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.